Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William B Messer

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Case Reports in Hematology|February 7, 2022
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic LeukemiaZoe L Lyski, Myung Sun Kim, David Xthona Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|August 29, 2022
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with ageTimothy A Bates, Pei Lu, Ye Jin Kang, et al.
Cell Reports|October 17, 2022
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with ageTimothy A Bates, Pei Lu, Ye Jin Kang, et al.
Mbio|December 19, 2024
The alphavirus determinants of intercellular long extension formationCaroline K Martin, Judy J Wan, Peiqi Yin, et al.
The Journal of Infectious Diseases|February 11, 2026
New insights into an old vaccine: potency and breadth of neutralizing antibodies elicited by the yellow fever vaccine 17D are boosted by heterologous Orthoflavivirus infectionFelicity J Coulter, Courtney A Micheletti, Abram E Estrada, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Previously infected vaccinees broadly neutralize SARS-CoV-2 variantsHans C Leier, Timothy A Bates, Zoe L Lyski, et al.
Blood Advances|December 6, 2021
Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemiaZoe L Lyski, Myung S Kim, David Xthona Lee, et al.
Science Immunology|January 25, 2022
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variantsTimothy A Bates, Savannah K McBride, Hans C Leier, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2018
Pervasive tertiary structure in the dengue virus RNA genomeElizabeth A Dethoff, Mark A Boerneke, Nandan S Gokhale, et al.
Influenza and Other Respiratory Viruses|June 10, 2026
Comparable Neutralizing Antibody Responses Following JN.1 and KP.2-Based COVID-19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity StudyLena Pracher, Mastura Wahedi, Anselm Jorda, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Case Reports in Hematology|February 7, 2022
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic LeukemiaZoe L Lyski, Myung Sun Kim, David Xthona Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|August 29, 2022
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with ageTimothy A Bates, Pei Lu, Ye Jin Kang, et al.
Cell Reports|October 17, 2022
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with ageTimothy A Bates, Pei Lu, Ye Jin Kang, et al.
Mbio|December 19, 2024
The alphavirus determinants of intercellular long extension formationCaroline K Martin, Judy J Wan, Peiqi Yin, et al.
The Journal of Infectious Diseases|February 11, 2026
New insights into an old vaccine: potency and breadth of neutralizing antibodies elicited by the yellow fever vaccine 17D are boosted by heterologous Orthoflavivirus infectionFelicity J Coulter, Courtney A Micheletti, Abram E Estrada, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Previously infected vaccinees broadly neutralize SARS-CoV-2 variantsHans C Leier, Timothy A Bates, Zoe L Lyski, et al.
Blood Advances|December 6, 2021
Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemiaZoe L Lyski, Myung S Kim, David Xthona Lee, et al.
Science Immunology|January 25, 2022
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variantsTimothy A Bates, Savannah K McBride, Hans C Leier, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2018
Pervasive tertiary structure in the dengue virus RNA genomeElizabeth A Dethoff, Mark A Boerneke, Nandan S Gokhale, et al.
Influenza and Other Respiratory Viruses|June 10, 2026
Comparable Neutralizing Antibody Responses Following JN.1 and KP.2-Based COVID-19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity StudyLena Pracher, Mastura Wahedi, Anselm Jorda, et al.
Pageof 9